Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cellectar Biosciences Inc (CLRB)

Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cellectar Biosciences Inc 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 USA

www.cellectar.com Employees: 11 P: 608-441-8120 F: 608-441-8121

Sector:

Medical

Description:

Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.

Key Statistics

Overview:

Market Capitalization, $K 15,222
Enterprise Value, $K -6,168
Shares Outstanding, K 4,240
Float, K 4,026
% Float 94.96%
Short Interest, K 106
Short Float 2.50%
Days to Cover 2.53
Short Volume Ratio 0.46
% of Insider Shareholders 5.04%
% of Institutional Shareholders 16.41%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -44,580 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,440 K
EBIT, $ -30,030 K
EBITDA, $ -29,740 K

Growth:

1-Year Return -50.59%
3-Year Return -92.08%
5-Year Return -99.38%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 91.58%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.41 on 11/13/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -9.00
EPS Growth vs. Prev Qtr 58.41%
EPS Growth vs. Prev Year 91.46%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 06/24/25

CLRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -214.33%
Return-on-Assets % -106.02%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.56
Book Value/Share 2.51
Interest Coverage -0.74
60-Month Beta 0.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar